Jackson Scott Thomas
Insider CIK 1566617 · MGNX Director · GLYC Director · NONE Chief Executive Officer, Director · SPRO Director · MURA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2026-06-23 | 2026-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2026-06-23 | 2026-06-25 | 10,000 | — | $0 | 85,000 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2026-05-19 | 2026-05-20 | 3,750 | — | $0 | 3,750 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2026-05-19 | 2026-05-20 | 22,000 | — | $0 | 22,000 | SEC↗ |
| MGNX MACROGENICS INC | M Exercise deriv | 2026-05-18 | 2026-05-20 | 3,750 | — | $0 | 0 | SEC↗ |
| MGNX MACROGENICS INC | M Exercise | 2026-05-18 | 2026-05-20 | 3,750 | — | $0 | 14,750 | SEC↗ |
| MURA Mural Oncology plc | D To issuer deriv | 2025-12-05 | 2025-12-05 | 15,021 | — | $0 | 0 | SEC↗ |
| MURA Mural Oncology plc | D To issuer deriv | 2025-12-05 | 2025-12-05 | 8,637 | — | $0 | 0 | SEC↗ |
| MURA Mural Oncology plc | D To issuer deriv | 2025-12-05 | 2025-12-05 | 8,462 | — | $0 | 0 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2025-06-12 | 2025-06-16 | 20,000 | — | $0 | 75,000 | SEC↗ |
| MURA Mural Oncology plc | A Award deriv | 2025-06-11 | 2025-06-13 | 8,637 | — | $0 | 8,637 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2025-05-21 | 2025-05-22 | 22,000 | — | $0 | 22,000 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2025-05-21 | 2025-05-22 | 3,750 | — | $0 | 3,750 | SEC↗ |
| MGNX MACROGENICS INC | M Exercise deriv | 2025-05-20 | 2025-05-22 | 6,500 | — | $0 | 0 | SEC↗ |
| MGNX MACROGENICS INC | M Exercise | 2025-05-20 | 2025-05-22 | 6,500 | — | $0 | 11,000 | SEC↗ |
| MURA Mural Oncology plc | A Award deriv | 2024-05-30 | 2024-06-03 | 8,462 | $3.35 | $28.3K | 8,462 | SEC↗ |
| MURA Mural Oncology plc | A Award deriv | 2024-05-30 | 2024-06-05 | 8,462 | — | $0 | 8,462 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2024-05-29 | 2024-05-30 | 20,000 | — | $0 | 55,000 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2024-05-21 | 2024-05-23 | 16,500 | — | $0 | 16,500 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2024-05-21 | 2024-05-23 | 6,500 | — | $0 | 6,500 | SEC↗ |
| MGNX MACROGENICS INC | M Exercise deriv | 2024-05-20 | 2024-05-22 | 4,500 | — | $0 | 0 | SEC↗ |
| MGNX MACROGENICS INC | M Exercise | 2024-05-20 | 2024-05-22 | 4,500 | — | $0 | 4,500 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2024-05-01 | 2024-05-01 | 40,000 | — | $0 | 40,000 | SEC↗ |
| MURA Mural Oncology plc | A Award deriv | 2023-12-14 | 2023-12-18 | 15,021 | — | $0 | 15,021 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2023-10-05 | 2023-10-10 | 20,000 | — | $0 | 35,000 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2023-05-31 | 2023-06-02 | 19,000 | — | $0 | 19,000 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2023-05-31 | 2023-06-02 | 4,500 | — | $0 | 4,500 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2023-05-19 | 2023-05-22 | 35,000 | — | $0 | 35,000 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2022-09-15 | 2022-09-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2022-05-19 | 2022-05-23 | 18,000 | — | $0 | 18,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2022-05-18 | 2022-05-20 | 21,000 | — | $0 | 21,000 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2021-08-17 | 2021-08-18 | 7,500 | — | $0 | 7,500 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2021-05-18 | 2021-05-27 | 10,500 | — | $0 | 10,500 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award | 2021-05-18 | 2021-05-27 | 5,250 | — | $0 | 5,250 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2021-05-13 | 2021-05-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2020-10-27 | 2020-10-27 | 7,500 | — | $0 | 7,500 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2020-06-23 | 2020-06-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2020-05-22 | 2020-05-27 | 21,000 | — | $0 | 21,000 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2020-05-14 | 2020-05-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2019-05-17 | 2019-05-21 | 21,000 | — | $0 | 21,000 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2019-05-16 | 2019-05-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2018-11-27 | 2018-11-28 | 22,000 | — | $0 | 22,000 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2018-05-17 | 2018-05-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2017-05-18 | 2017-05-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MGNX MACROGENICS INC | A Award deriv | 2017-01-24 | 2017-01-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CPXX Celator Pharmaceuticals In | D To issuer deriv | 2016-07-12 | 2016-07-12 | 295,000 | $28.93 | $8.53M | 0 | SEC↗ |
| CPXX Celator Pharmaceuticals In | D To issuer deriv | 2016-07-12 | 2016-07-12 | 157,000 | $27.03 | $4.24M | 0 | SEC↗ |
| CPXX Celator Pharmaceuticals In | D To issuer deriv | 2016-07-12 | 2016-07-12 | 175,000 | $27.46 | $4.81M | 0 | SEC↗ |
| CPXX Celator Pharmaceuticals In | D To issuer deriv | 2016-07-12 | 2016-07-12 | 333,724 | $27.13 | $9.05M | 0 | SEC↗ |
| CPXX Celator Pharmaceuticals In | D To issuer deriv | 2016-07-12 | 2016-07-12 | 98,409 | $27.81 | $2.74M | 0 | SEC↗ |
| CPXX Celator Pharmaceuticals In | D To issuer deriv | 2016-07-12 | 2016-07-12 | 118,835 | $28.93 | $3.44M | 0 | SEC↗ |
| CPXX Celator Pharmaceuticals In | D To issuer | 2016-07-12 | 2016-07-12 | 301,518 | $30.25 | $9.12M | 0 | SEC↗ |
| CPXX Celator Pharmaceuticals In | M Exercise deriv | 2016-07-07 | 2016-07-07 | 117,064 | — | $0 | 98,409 | SEC↗ |
| CPXX Celator Pharmaceuticals In | M Exercise deriv | 2016-07-07 | 2016-07-07 | 38,135 | — | $0 | 0 | SEC↗ |
| CPXX Celator Pharmaceuticals In | M Exercise deriv | 2016-07-07 | 2016-07-07 | 96,276 | — | $0 | 333,724 | SEC↗ |
| CPXX Celator Pharmaceuticals In | M Exercise | 2016-07-07 | 2016-07-07 | 96,276 | $3.12 | $300.4K | 301,518 | SEC↗ |
| CPXX Celator Pharmaceuticals In | M Exercise | 2016-07-07 | 2016-07-07 | 38,135 | $3.37 | $128.5K | 88,178 | SEC↗ |
| CPXX Celator Pharmaceuticals In | M Exercise | 2016-07-07 | 2016-07-07 | 117,064 | $2.44 | $285.6K | 205,242 | SEC↗ |
| CPXX Celator Pharmaceuticals In | A Award deriv | 2016-01-27 | 2016-01-29 | 118,835 | — | $0 | 118,835 | SEC↗ |
| CPXX Celator Pharmaceuticals In | A Award deriv | 2016-01-27 | 2016-01-29 | 295,000 | — | $0 | 295,000 | SEC↗ |
| CPXX Celator Pharmaceuticals In | P Buy | 2015-10-06 | 2015-10-07 | 14,450 | $1.74 | $25.1K | 50,043 | SEC↗ |
| CPXX Celator Pharmaceuticals In | A Award deriv | 2015-02-25 | 2015-02-27 | 175,000 | — | $0 | 175,000 | SEC↗ |
| CPXX Celator Pharmaceuticals In | A Award | 2015-02-25 | 2015-02-27 | 22,593 | — | $0 | 35,593 | SEC↗ |
| CPXX Celator Pharmaceuticals In | P Buy | 2014-11-18 | 2014-11-18 | 10,000 | $2.20 | $22.0K | 13,000 | SEC↗ |
| CPXX Celator Pharmaceuticals In | A Award deriv | 2014-02-18 | 2014-02-20 | 157,000 | — | $0 | 157,000 | SEC↗ |
| CPXX Celator Pharmaceuticals In | P Buy | 2013-12-17 | 2013-12-17 | 3,000 | $3.50 | $10.5K | 3,000 | SEC↗ |
| NONE Celator Pharmaceuticals In | A Award deriv | 2013-06-03 | 2013-08-27 | 430,000 | — | $0 | 430,000 | SEC↗ |